256 related articles for article (PubMed ID: 24441149)
1. Integrated genome-wide genotyping and gene expression profiling reveals BCL11B as a putative oncogene in acute myeloid leukemia with 14q32 aberrations.
Abbas S; Sanders MA; Zeilemaker A; Geertsma-Kleinekoort WM; Koenders JE; Kavelaars FG; Abbas ZG; Mahamoud S; Chu IW; Hoogenboezem R; Peeters JK; van Drunen E; van Galen J; Beverloo HB; Löwenberg B; Valk PJ
Haematologica; 2014 May; 99(5):848-57. PubMed ID: 24441149
[TBL] [Abstract][Full Text] [Related]
2. 14q32 rearrangements deregulating BCL11B mark a distinct subgroup of T-lymphoid and myeloid immature acute leukemia.
Di Giacomo D; La Starza R; Gorello P; Pellanera F; Kalender Atak Z; De Keersmaecker K; Pierini V; Harrison CJ; Arniani S; Moretti M; Testoni N; De Santis G; Roti G; Matteucci C; Bassan R; Vandenberghe P; Aerts S; Cools J; Bornhauser B; Bourquin JP; Piazza R; Mecucci C
Blood; 2021 Sep; 138(9):773-784. PubMed ID: 33876209
[TBL] [Abstract][Full Text] [Related]
3. HELIOS-BCL11B fusion gene involvement in a t(2;14)(q34;q32) in an adult T-cell leukemia patient.
Fujimoto R; Ozawa T; Itoyama T; Sadamori N; Kurosawa N; Isobe M
Cancer Genet; 2012; 205(7-8):356-64. PubMed ID: 22867996
[TBL] [Abstract][Full Text] [Related]
4. Tcrδ translocations that delete the Bcl11b haploinsufficient tumor suppressor gene promote atm-deficient T cell acute lymphoblastic leukemia.
Ehrlich LA; Yang-Iott K; Bassing CH
Cell Cycle; 2014; 13(19):3076-82. PubMed ID: 25486566
[TBL] [Abstract][Full Text] [Related]
5. A novel t(6;14)(q25-q27;q32) in acute myelocytic leukemia involves the BCL11B gene.
Bezrookove V; van Zelderen-Bhola SL; Brink A; Szuhai K; Raap AK; Barge R; Beverstock GC; Rosenberg C
Cancer Genet Cytogenet; 2004 Feb; 149(1):72-6. PubMed ID: 15104287
[TBL] [Abstract][Full Text] [Related]
6. Successful treatment of a child with T/myeloid acute bilineal leukemia associated with TLX3/BCL11B fusion and 9q deletion.
Oliveira JL; Kumar R; Khan SP; Law ME; Erickson-Johnson M; Oliveira AM; Ketterling RP; Dogan A
Pediatr Blood Cancer; 2011 Mar; 56(3):467-9. PubMed ID: 21225930
[TBL] [Abstract][Full Text] [Related]
7. Activation of TLX3 and NKX2-5 in t(5;14)(q35;q32) T-cell acute lymphoblastic leukemia by remote 3'-BCL11B enhancers and coregulation by PU.1 and HMGA1.
Nagel S; Scherr M; Kel A; Hornischer K; Crawford GE; Kaufmann M; Meyer C; Drexler HG; MacLeod RA
Cancer Res; 2007 Feb; 67(4):1461-71. PubMed ID: 17308084
[TBL] [Abstract][Full Text] [Related]
8. Enhancer Hijacking Drives Oncogenic
Montefiori LE; Bendig S; Gu Z; Chen X; Pölönen P; Ma X; Murison A; Zeng A; Garcia-Prat L; Dickerson K; Iacobucci I; Abdelhamed S; Hiltenbrand R; Mead PE; Mehr CM; Xu B; Cheng Z; Chang TC; Westover T; Ma J; Stengel A; Kimura S; Qu C; Valentine MB; Rashkovan M; Luger S; Litzow MR; Rowe JM; den Boer ML; Wang V; Yin J; Kornblau SM; Hunger SP; Loh ML; Pui CH; Yang W; Crews KR; Roberts KG; Yang JJ; Relling MV; Evans WE; Stock W; Paietta EM; Ferrando AA; Zhang J; Kern W; Haferlach T; Wu G; Dick JE; Klco JM; Haferlach C; Mullighan CG
Cancer Discov; 2021 Nov; 11(11):2846-2867. PubMed ID: 34103329
[TBL] [Abstract][Full Text] [Related]
9. T(6;14)(q25;q32) involves BCL11B and is highly associated with mixed-phenotype acute leukemia, T/myeloid.
Wang W; Beird H; Kroll CJ; Hu S; Bueso-Ramos CE; Fang H; Tang G; Tang Z; Wang F; Takahashi K; You MJ; Khoury JD; Medeiros LJ; Futreal PA
Leukemia; 2020 Sep; 34(9):2509-2512. PubMed ID: 32099038
[No Abstract] [Full Text] [Related]
10. Novel ZEB2-BCL11B Fusion Gene Identified by RNA-Sequencing in Acute Myeloid Leukemia with t(2;14)(q22;q32).
Torkildsen S; Gorunova L; Beiske K; Tjønnfjord GE; Heim S; Panagopoulos I
PLoS One; 2015; 10(7):e0132736. PubMed ID: 26186352
[TBL] [Abstract][Full Text] [Related]
11. NUP98-HOXA9 bearing therapy-related myeloid neoplasm involves myeloid-committed cell and induces HOXA5, EVI1, FLT3, and MEIS1 expression.
Burillo-Sanz S; Morales-Camacho RM; Caballero-Velázquez T; Vargas MT; García-Lozano JR; Falantes JF; Prats-Martín C; Bernal R; Pérez-Simón JA
Int J Lab Hematol; 2016 Feb; 38(1):64-71. PubMed ID: 26418229
[TBL] [Abstract][Full Text] [Related]
12. Disruption of the BCL11B gene through inv(14)(q11.2q32.31) results in the expression of BCL11B-TRDC fusion transcripts and is associated with the absence of wild-type BCL11B transcripts in T-ALL.
Przybylski GK; Dik WA; Wanzeck J; Grabarczyk P; Majunke S; Martin-Subero JI; Siebert R; Dölken G; Ludwig WD; Verhaaf B; van Dongen JJ; Schmidt CA; Langerak AW
Leukemia; 2005 Feb; 19(2):201-8. PubMed ID: 15668700
[TBL] [Abstract][Full Text] [Related]
13. Functional characterization of common BCL11B gene desert variants suggests a lymphocyte-mediated association of BCL11B with aortic stiffness.
Maskari RA; Hardege I; Cleary S; Figg N; Li Y; Siew K; Khir A; Yu Y; Liu P; Wilkinson I; O'Shaughnessy K; Yasmin
Eur J Hum Genet; 2018 Nov; 26(11):1648-1657. PubMed ID: 30089823
[TBL] [Abstract][Full Text] [Related]
14. BCL11B rearrangements probably target T-cell neoplasia rather than acute myelocytic leukemia.
MacLeod RA; Nagel S; Drexler HG
Cancer Genet Cytogenet; 2004 Aug; 153(1):88-9. PubMed ID: 15325104
[No Abstract] [Full Text] [Related]
15. The Ig heavy chain gene is frequently involved in chromosomal translocations in multiple myeloma and plasma cell leukemia as detected by in situ hybridization.
Nishida K; Tamura A; Nakazawa N; Ueda Y; Abe T; Matsuda F; Kashima K; Taniwaki M
Blood; 1997 Jul; 90(2):526-34. PubMed ID: 9226151
[TBL] [Abstract][Full Text] [Related]
16. CDKN1B, encoding the cyclin-dependent kinase inhibitor 1B (p27), is located in the minimally deleted region of 12p abnormalities in myeloid malignancies and its low expression is a favorable prognostic marker in acute myeloid leukemia.
Haferlach C; Bacher U; Kohlmann A; Schindela S; Alpermann T; Kern W; Schnittger S; Haferlach T
Haematologica; 2011 Jun; 96(6):829-36. PubMed ID: 21422114
[TBL] [Abstract][Full Text] [Related]
17. Incidence and characterization of MLL gene (11q23) rearrangements in acute myeloid leukemia M1 and M5.
Poirel H; Rack K; Delabesse E; Radford-Weiss I; Troussard X; Debert C; Leboeuf D; Bastard C; Picard F; Veil-Buzyn A; Flandrin G; Bernard O; Macintyre E
Blood; 1996 Mar; 87(6):2496-505. PubMed ID: 8630416
[TBL] [Abstract][Full Text] [Related]
18. Identification of a potential "hotspot" DNA region in the RUNX1 gene targeted by mitoxantrone in therapy-related acute myeloid leukemia with t(16;21) translocation.
Ottone T; Hasan SK; Montefusco E; Curzi P; Mays AN; Chessa L; Ferrari A; Conte E; Noguera NI; Lavorgna S; Ammatuna E; Divona M; Bovetti K; Amadori S; Grimwade D; Lo-Coco F
Genes Chromosomes Cancer; 2009 Mar; 48(3):213-21. PubMed ID: 19023877
[TBL] [Abstract][Full Text] [Related]
19. Combined interphase fluorescence in situ hybridization elucidates the genetic heterogeneity of T-cell acute lymphoblastic leukemia in adults.
Gorello P; La Starza R; Varasano E; Chiaretti S; Elia L; Pierini V; Barba G; Brandimarte L; Crescenzi B; Vitale A; Messina M; Grammatico S; Mancini M; Matteucci C; Bardi A; Guarini A; Martelli MF; Foà R; Mecucci C
Haematologica; 2010 Jan; 95(1):79-86. PubMed ID: 20065082
[TBL] [Abstract][Full Text] [Related]
20. Myeloid neoplasms with t(16;21)(q24;q22)/RUNX1-RUNX1T3 mimics acute myeloid leukemia with RUNX1-RUNX1T1.
Liu H; Wang SA; Schlette EJ; Xu J; Jorgensen JL; Cameron Yin C; Li S; Jeffrey Medeiros L; Tang G
Ann Hematol; 2018 Oct; 97(10):1775-1783. PubMed ID: 29872884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
